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Available online 21 June 2017Viral infections are amajor burden to human and animal health. Immune response against viruses consists of in-
nate and adaptive immunity which are both critical for the eradication of the viral infection. The innate immune
system is the first line of defense against viral infections. Proper innate immune response is required for the ac-
tivation of adaptive, humoral and cell-mediated immunity. Macrophages are innate immune cells which have a
central role in detecting viral infections including influenza A and human immunodeficiency viruses. Macro-
phages and other host cells respond to viral infection by modulating their protein expression levels, proteins'
posttranslationalmodifications, aswell as proteins' intracellular localization and secretion. Therefore the detailed
characterization how viruses dynamically manipulate host proteome is needed for understanding the molecular
mechanisms of viral infection. It is critical to identify cellular host factorswhich are exploited by different viruses,
and which are less prone for mutations and could serve as potential targets for novel antiviral compounds. Here,
we review how proteomics studies have enhanced our understanding of macrophage response to viral infection
with special focus on Influenza A and Human immunodeficiency viruses, and virus infections of swine.
Significance: Influenza A viruses (IAVs) and human immunodeficiency viruses (HIV) infect annually millions of
peopleworldwide and they form a severe threat to human health. Both IAVs and HIV-1 can efficiently antagonize
host response and develop drug-resistant variants. Most current antiviral drugs are directed against viral pro-
teins, and there is a constant need to develop new next-generation drugs targeting host proteins that are essen-
tial for viral replication. Porcine reproductive and respiratory syndrome virus (PRRSV) and porcine circovirus
type 2 (PCV2) are economically important swine pathogens. Both PRRSV and PCV2 cause severe respiratory
tract illnesses in swine. IAVs, HIV-1, and swine viruses infect macrophages activating antiviral response against
these viruses. Macrophages also have a central role in the replication and spread of these viruses. However, mac-
rophage response to these viruses is incompletely understood. Current proteomicsmethods can provide a global
view of host-response to viral infection which is needed for in-depth understanding the molecular mechanisms
of viral infection. Here we review the current proteomics studies on macrophage response to viral infection and
provide insight into the global host proteome changes upon viral infection.
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Fig. 1. Viruses havemultipleways of to capture andmanipulate host cellular processes for
their replication and spread. Viral infection can modulate host cell proteome at multiple
levels. Viral proteins also interact with host cells proteins, and proteomics provides tools
to characterize these interactions.
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human and swine pathogenic viruses
Macrophages are innate immune cells which have a central role in
detecting viral infections including influenza A and human immunode-
ficiency viruses. They are found in all parts of the body, and they consti-
tute 5–15% of cells depending on tissue. They show great functional
diversity and in addition to activating innate immune response they
have central roles in development, homeostasis, and tissue repair. Acti-
vation of macrophages by viral infection results in antiviral response
and inflammation aiming to pathogen elimination. Upon activation,
macrophages start to secrete cytokines to mount inflammatory re-
sponse, chemokines to recruit other immune cells to the site of infection
or inflammation, and other proteins inducing antiviral defense and tis-
sue regeneration.
Influenza A viruses (IAVs) and human immunodeficiency viruses
(HIV) infect annually millions of people worldwide and they form a se-
vere threat to human health. Both viruses have single-stranded RNA ge-
nomes. IAVs have negative-stranded RNA genome and they replicate
through positive-stranded RNA whereas HIVs replicate through a DNA
intermediate to produce viral RNA. IAVs belong to Orthomyxoviridae
family that are capable of infecting humans, birds, and swine. They are
respiratory pathogens that spread around the world in seasonal epi-
demics, resulting in the deaths of hundreds of thousandsworldwide an-
nually, and millions in pandemic years (http://who.int/topics/
influenza/en/).
InfectionwithHIV is pandemicwith N30million people estimated to
be infected worldwide (http://www.who.int/hiv/en/). HIV is a human
retrovirus that targets cells within the immune system and establishes
lifelong infection resulting in immunodeficiency and the development
of AIDS. Several drugs against HIV-1 and IAV are available and many
are in development. Both IAVs and HIV-1 can efficiently antagonize
host response and develop drug-resistant variants. Most current antivi-
ral drugs are directed against viral proteins, and there is a constant need
to develop new next-generation drugs targeting host proteins that are
essential for viral replication.
The primary targets of IAVs are the epithelial cells of the upper respi-
ratory tract. IAVs also infect alveolar macrophages that have a central
role in controlling the spread of IAVs. Both macrophages and CD4-posi-
tive T cells are important target cells for the Human Immunodeficiency
Virus Type I (HIV-1). Macrophages are much more resistant to cyto-
pathic effects of lentiviral replication than CD4-positive T cells. HIV-in-
fected macrophages represent a stable viral reservoir with continuous
virus production contributing to the pathogenesis of HIV-1 infection. It
has been suggested that interaction of HIV-1 with macrophages is cru-
cial at all stages of HIV-1 infection [1].
In addition to IAVs, porcine reproductive and respiratory syndrome
virus (PRRSV) and porcine circovirus type 2 (PCV2) are economically
important swine pathogens [2]. PRRSV and PCV2 cause respiratory
tract illness and postweaning multisystemic wasting syndrome in
swines, respectively. Both of these viruses replicate in macrophages
and this virus-macrophage interaction essentially contributes to the
pathogenesis of these porcine viruses. However, the macrophage re-
sponse to these swine viruses is incompletely understood.
2. Proteomics to study macrophage response to viral infection
Viruses have coevolved with their hosts, and have multiple ways of
to capture and manipulate host cellular processes for their replication
and spread. Macrophages and other host cells respond to viral infection
bymodulating their protein expression levels, proteins' posttranslation-
al modifications, as well as proteins' intracellular localization and secre-
tion. Therefore detailed characterization how viruses dynamically
manipulate host proteome is needed for understanding the molecular
mechanisms of viral infection. Current proteomicsmethods can provide
a global view of host-response to viral infection, both related to host cellresponse to virus and how viral proteins interact with host proteins
(Fig. 1).
In proteomics, the first ‘workhorse’ technique was two-dimensional
electrophoresis (2-DE) combined with protein identification by mass
spectrometry (MS). This combination was by far the most commonly
used proteomics platform in 1990's and early 2000's. The main advan-
tage of 2-DE is that it has excellent separation efficiency for intact pro-
teins, and even protein isoforms can be separated into distinct spots.
Also post-translationally modified or truncated/fragmented proteins
will be separated fromnon-modified/intact proteins. However, 2-DE re-
quires a lot of manual lab work and the reproducibility of the gels is
highly dependent on the skills of the person running the gels. Also the
quantification accuracy depends on the stainingmethod used and com-
parison analysis of the gels can be time-consuming. The developments
of high-resolution MS, optimized sample preparation protocols and ad-
vanced data-analysis tools have made proteomics very MS-centric dur-
ing the last decade. This can also be clearly seenwith proteomics studies
on viral infection where majority of the new publications employ vari-
ousMS-based proteomicsworkflows. A powerful example of this is a re-
cent study by Weekes et al. who developed a MS-based proteomic
technique called “quantitative temporal viromics” [3] and used it to
characterize Human cytomegalovirus (HCMV) infection in primary
human fetal foreskin fibroblasts. They quantified N8000 proteins from
fibroblasts including N1000 cell-surface proteins and 81% of all canoni-
cal HCMV proteins over eight time points during productive infection,
providing a near-complete temporal view of the host proteome and
HCMV virome.
Macrophages responses to IAV and HIV have been extensively
studied using different proteomics workflows including 2-DE and
MS-based methods (Tables 1 and 2). Different proteomic methods
have also been used to study pulmonary alveolar macrophages fol-
lowing porcine reproductive and respiratory syndrome virus
(PRRSV) and porcine circovirus type 2 infection (Table 3). The prote-
omic methods used in different studies are summarized in Fig. 2.
With HIV, earliest proteomics reports were using SELDI-TOF Protein
Chips [4–10] which is a variant of MALDI analysis. SELDI-TOF com-
bines surface-enhanced selective capture of proteins with their
time-of-flight separation and detection, however SELDI alone is not
capable of identifying proteins from the samples and is therefore of
limited use anymore. These studies identified several proteins that
were differentially expressed in sera from HIV-infected individuals
with or without HIV-1-associated dementia [11].
In host-virus protein interaction studies, different affinity purifica-
tion (AP) methods are combined with MS-based protein identification
Table 1
Proteomic analysis of macrophage response to influenza A virus infection and proteomic studies of influenza viruses.
Reference IAV strain Host cell Proteomic method(s)
Öhman 2009 [19] Udorn/307/1972 (H3N2) Human monocyte-derived
macrophages
Subcellular proteomics; 2-DE and MS
Lietzen 2011 [25] Udorn/307/1972 (H3N2)* Human monocyte-derived
macrophages
Subcellular proteomics and secretomics combined with kinetic analysis; iTRAQ
and LC-MS/MS
Zhu 2012 [20] F9/10 and 34/06 swine viruses
(H1N1)
Porcine alveolar macrophages Kinetic analysis of total cellular lysates; 2-DE and MS
Liu 2012 [16] PR/8/34 (H1N1) Human alveolar macrophages Total cellular lysates, SILAC
Cheung 2012 [24] Vietnam/3212/04 (H5N1) Human monocyte-derived
macrophages
Kinetic analysis of total cellular lysates, label-free quantification
Söderholm 2016
[31]
Udorn/307/1972 (H3N2) Human monocyte-derived
macrophages
Phosphoproteomics (IMAC and LC-MS/MS) combined with functional studies
Cypryk 2016 [48] Udorn/307/1972 (H3N2) Human monocyte-derived
macrophages
Extracellular vesicle analysis by LC-MS/MS
*Also Beijing/353/89
Reference Proteomics of influenza virus proteins
Hutchinson 2012 [32] Mapping the phosphoproteome of influenza A and B viruses by mass spectrometry
Hutchinson 2014 [57] Conserved and host-specific features of influenza virion architecture
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omics applied to virology for most host cell types and viral infections
[12]. As an example, Heaton et al. [13] used AP-MS to generate an inter-
actome map of host and IAV proteins during an active infection inTable 2
Proteomic studies of macrophages upon HIV infection and proteome analysis of HIV virions.
Reference SELDI-TOF protein chip
Luo 2003 [4] Macrophage proteomic fingerprinting predicting HIV-1-associa
Carlson 2004 [5] A preliminary report for proteomic fingerprinting of HIV-1-infe
Wojna 2004 [6] Proteomic fingerprinting of human immunodeficiency virus typ
Kadiu 2007 [7] Secretome analyses of culture fluids derived from HIV-1 infecte
Luciano-Montalvo 2008
[8]
Proteomics to identify differences between the uninfected and
Garcia 2009 [9] SELDI-TOF to test the hypothesis that placental macrophages se
replication
Toro-Nieves 2009 [10] Cell lysates of uninfected and HIV-1-infected MDMs at 14 days
DIGE
Ricardo-Dukelow 2007
[70]
Proteomics to determine the effects that HIV-1-infected macrop
Wang 2008 [23] MP-astrocyte crosstalk was investigated by DIGE and MS analys
Wang 2008 [22] Proteomics study of co-culture systems of HIV-infected mouse a
Kadiu 2011 [71] DIGE and MS analysis of bridging conduits from HIV infected M
Other
Ciborowski 2004 [72] Analysis of conditioned serum-free medium of HIV-1ADA-infec
Ciborowski 2007 [52] Secretome analysis of HIV-1-infected human monocyte-derived
Brown 2008 [73] Immunoblot analysis of about 1000 intracellular proteins from
Luciano-Montalvo 2009
[74]
IP-studies showing that the levels of STAT-1 tyrosine phosphory
and MDM are differentially regulated
MS-based proteomics
Pathak 2009 [75] The effects of HIV infection on the protein profile of undifferent
Huang 2010 [76] iTRAQ to identify differential protein expression between HIV-1
Kraft-Terry 2011 [34] Alterations in de novo protein synthesis of HIV-1 infected huma
Raposo 2011 [77] Large-scale anti-CD4 IPs in human primary Mφ followed by hig
Kadiu 2012 [55] Cytokine arrays and GeLC-MS/MS characterization of the proteo
and exosome proteomes
Barrero 2013 [36] SILAC to to characterize the Human immunodeficiency virus typ
Haverland 2014 [35] Quantitative proteomics by SWATH-MS reveals altered express
Arainga 2015 [78] SWATH-MS proteomics and cell profiling to nanoparticle atazan
Du 2015 [79] iTRAQ analysis of equine monocyte-derived macrophages infec
Cantares-Rosario 2015
[54]
Label-fee quantification and identification of macrophage-secre
Colon 2016 [53] Macrophage secretome analysis using iTRAQ from women with
Ganji 2016 [18] Proteomics of phagosome-enriched fractions from Mycobacteri
co-infected THP-1 cells by LC-MALDI-MS/MS
Proteome analysis of HIV virions using MS-based approaches
Chertova 2006 [80] Proteome characterization of highly purified HIV-1 virions prod
Santos 2012 [81] GeLC-MS/MS-based proteome analysis of HIV-1 viral cores
Linde 2013 [58] Determining the host protein composition in HIV virions usinghuman lung epithelial cell line A549. They generated fully infectious
tagged influenza viruses and used infection-based proteomics to identi-
fy pivotal arms of cellular signaling required for influenza virus growth
and infectivity. However, with macrophages very little has been doneted cognitive impairment
cted human MDMs
e 1-associated dementia (a case study)
d monocyte-derived macrophages
HIV-infected PM and MDM protein profiles linked to viral growth
crete different proteins as compared to MDM that may contribute to decreased HIV-1
post infection analyzed by SELDI-TOF
hages have on human brain microvascular endothelial cell (HBMEC) protein profiles
is using vesicular stomatitis virus pseudotyped HIV infected murine microglia
strocytes and microglia
DMs
ted and uninfected cells using SDS-PAGE and MS
macrophages using SDS-PAGE and MS
human macrophages over the course of HIV-1 infection
lation (but not serine phosphorylation) between uninfected and HIV-infected PM
iated monocyte-like THP-1 cells were examined using SILAC
-infected bone marrow-derived macrophages with and without Treg
n MDMs were examined after 3, 5, and 7 days of viral infection using SILAC
h-resolution MS
mes from unfractionated MV and exosomes (Uninfected Vesicles) and infected MV
e 1 encoded viral protein (Vpr) response in macrophages
ion of nucleic acid binding and regulatory proteins in HIV-1-infected macrophages
avir (nanoATV)-treated and HIV-1 infected human MDMs
ted with equine infectious anemia virus
ted cathepsin B protein interactions extracellularly
HIV-associated neurocognitive disorders
um bovis Bacillus Calmette-Guérin (BCG) mono-infected and HIV-M. bovis BCG
uced from human monocyte-derived macrophages (MDMs)
alternative purification technique (density modification, DM) and iTRAQ
Table 3
Proteomic analysis of porcine alveolar macrophages infected with PRRSV or PCV2.
Reference Virus Infection time and proteomic method(s)
Ding 2012
[37]
PRRSV 24 h Infection, 2-DE analysis of total cellular lysate
Zhou 2014
[38]
PRRSV 48 h Infection, DIGE of total cellular lysate; comparison of
host response to highly pathogenic virus strain and
attenuated strain
Lu 2012
[39]
PRRSV Kinetic study (12 h,24 h,36 h and 48 h infection) of total
cellular lysates; iTRAQ
Liu 2013
[40]
PCV2 Kinetic study (12 h,24 h,36 h and 48 h infection) of total
cellular lysates; iTRAQ
Luo 2014
[41]
PRRSV 12 h and 36 h infection, phosphopeptide enrichment with
TiO2 and label-free quantitative phosphoproteomics
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response to viral infection.
2.1. Macrophage models used in proteomics studies
Macrophages are heterogeneous and versatile cells found in virtually
all tissues. Tissuemacrophages are derived from embryonic progenitorsFig. 2. Summary of proteomics methods used to characterize virus infection in macrophages. B
common. These different MS-based methods have been recently reviewed [67–69].and they renew independently of hematopoietic stem cells [14]. During
infection or injury, large amounts of monocytes are recruited from the
circulation and they differentiate to macrophages as they migrate into
the affected tissue. Most experimental systems that study macrophage
responses to virus infections use monocyte-derived macrophages
(MDMs). Monocytes can be differentiated into macrophages in the
presence of granulocyte-macrophage colony-stimulating factor (GM-
CSF) or macrophage colony-stimulating factor (M-CSF). M-CSF macro-
phages resemble tissue macrophages that promote healing and growth
whereas GM-CSF macrophages are pro-inflammatory. GM-CSF macro-
phages also resemble alveolar macrophages [15] and therefore they
are a good model system to study the effect of IAV infection on macro-
phage response. Very few studies have utilized primary human macro-
phages in proteomics studies, for example human primary alveolar
macrophages have been used to study host response to IAV infection
[16].
In proteomics studies cell lines have been widely used. The main
advantage of using cell lines is that they are easy to culture and it is
possible to obtain large amounts of starting material. THP-1, U-937,
and HL-60 are myeloid leukemia cell lines which can be differentiated
into macrophage-like adherent cells after treatment with phorboloth gel- and MS-based have been used, but at present, the MS-based workflows are more
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macrophage biology. THP-1 cells differentiate into macrophage-like
cells which mimic native monocyte-derived macrophages in some re-
spects. However, it is important to recognize that THP-1 cells and pri-
mary monocyte–macrophages have significant differences [17]. Some
proteomics studies have utilized THP-1 cells: Ganji et al. have used
THP-1 cells to study the effect of mycobacteria and HIV-1 co-infection
on mycobacterial protein expression [18].
2.2. Two-dimensional electrophoresis based proteome studies of IAV and
HIV infected macrophages
Proteome changes in macrophages upon IAV infection have been
studied using 2-DE based proteomics by us and others [19,20]. Öhman
et al. [19] and Zhu et al. [20] used 2-DE with silver-staining followed
by in-gel digestion and MALDI-TOF/TOF analysis for protein identifica-
tion to characterize influenza virus infected macrophages. Öhman et
al. fractionated human MDMs into mitochondria and cytoplasm, and
analyzed these fractions separately to gain sub-cellular information on
protein changes [19] whereas Zhu et al. performed a kinetic analysis
of IAV-infected porcine macrophages [20]. Both studies found marked
changes in cytoskeletal proteins upon IAV infection. We elucidated
this further and showed that actin undergoes fragmentation, and
these fragments translocate into mitochondria upon IAV infection
[19]. Our results suggest that actin fragments, fractins, are involved in
the disruption of mitochondrial membranes during apoptosis of virus-
infected cells. Actin fragmentation was associated with mitochondrial
translocation of RIG-I/MAVS signaling components, which are involved
in viral genome recognition and activation of antiviral cytokine produc-
tion. We also showed that intact actin cytoskeleton structure is crucial
for proper activation of antiviral response. Later we made a similar ob-
servation in human keratinocytes which were transfected with
poly(I:C) mimicking double-stranded RNA that is formed during viral
replication [21], and showed that cytokeratin network is disrupted in
a caspase-dependent manner upon dsRNA stimulation as well as upon
Encephalomyocarditis virus or Vesicular stomatitis virus infection.
These studies also nicely illustrate the power of 2-DE analysis to detect
protein fragmentation events.
HIV infection inmicroglia, which act as themain immune cells of the
central nervous system, has been studied using DIGE [22–23], a variant
of 2-DE where samples are labelled with different fluorescent dyes,
mixed, and the proteins are separated in one 2-DE gel. Labelled proteins
are visualized with scanning the gel with different excitation wave-
lengths, and the resulting protein patterns are compared. The main ad-
vantage of DIGE is that it avoids the inter-gel variation of standard 2-DE
where all the samples are analyzed with individual gels, in addition, the
quantification accuracy of DIGE is very good compared to e.g. silver-
staining. Wang and co-workers utilized DIGE and co-culture systems
of HIV-1-infected mouse astrocytes and microglia to study the effect
of HIV-1-infected astrocytes on the biology of microglia [23]. They pro-
vided novel information that HIV-1-infected astrocytes increase the
neurotoxicity of HIV-1-infected microglia. The findings suggest that
the dynamics of permissive and productive HIV-1 infection in microglia
is regulated by intercellular interactions with infected astrocytes, and
promote HIV-1 related neuroinflammation and neurodegeneration.
2.3. MS-based proteomics studies of macrophage response to influenza A
virus infection
Several recent reports have usedMS-based proteomics to character-
ize IAV infection in macrophages. Cheung et al. [24] used label-free
quantitative proteomics to characterize differences in highly pathogenic
H5N1 and seasonal H1N1 influenza virus infection in MDMs and Liu et
al. [16] used SILAC to characterizeH1N1 IAV infection in human alveolar
macrophages. Both these studies were done using total cellular lysates.
The work by Cheung et al. [24] showed that highly pathogenic H5N1strain of IAV induces significant changes in MDM proteome already at
1 h post-infection, especially in proteins related to translationalmachin-
ery. Liu et al. identified a total of 1214 proteins from alveolar macro-
phages, and 875 of those proteins were reliably quantified [16]. The
expression of 106 proteins was statistically significantly altered at
24 h post-infection, and a high up-regulation of interferon inducible
proteins was seen [16]. In addition, the expression of proteins involved
in inflammatory response, apoptosis, and redox state was altered in re-
sponse to IAV infection.
To gain spatio-temporal information how IAV manipulates macro-
phage proteome, we performed a kinetic, quantitative sub-cellular pro-
teome analysis of human MDMs [25]. We analyzed the changes in
nuclear, mitochondrial and cytoplasmic proteomes, as well as in the
global protein secretion (secretome) upon IAV infection in three time-
points using iTRAQ. We identified almost 3500 distinct proteins and
showed that viral infection regulates the expression and/or subcellular
localization of more than one thousand host proteins at early phases
of infection [25].
NLRP3 inflammasomes are multimeric cytosolic protein complexes
of the innate immune system that are activated in humanmacrophages
in response to viral infection. Upon activation NLRP3 inflammasomes
induce inflammation and they are essential for the antimicrobial de-
fense. Assembly of NLRP3 inflammasome triggers the activation of in-
flammatory cysteine protease caspase-1 and following proteolytic
processing and secretion of pro-inflammatory cytokines Interleukin
(IL)-1β and IL-18. The function of NLRP3 inflammasome in caspase-1-
mediated processing of these cytokines during influenza A virus infec-
tion was demonstrated almost two decades ago [26]. After this, experi-
ments with NLRP3 deficient mice have confirmed the central role of
NLRP3 inflammasome in innate immune response against IAV infection
in vivo [27–29]. Our proteomic study [25] demonstrated a rapid cyto-
plasmic leakage of lysosomal proteases, cathepsins, and the secretion
of these enzymes following influenza A virus infection of humanmacro-
phages. Following functional studies showed that cathepsin activity is
essential for NLRP3 inflammasome activation in response to influenza
A virus infection [25]. In another study we used GeLC-MS/MS analysis
to characterize the secretome of macrophages that had been activated
through cytoplasmic dsRNA-recognition pathways [30]. This showed
that cathepsin secretion is activated upon dsRNA, and similarly to
virus infection this dsRNA-induced NLRP3 inflammasome activation
was dependent on cathepsin activity [30]. These proteomics studies
have revealed novel mechanisms how NLRP3 inflammasome is activat-
ed in humanmacrophages during viral infection [25,30]. Our sub-cellu-
lar proteomics study also showed that Bax is translocated onto the
mitochondria and cytochrome c leaks into the cytoplasm in response
to influenza A virus infection [25]. These translocations are classical
signs of mitochondrial apoptosis, programmed cell death and in line
with the results by Liu et al. on macrophage response to H1N1 infection
[16]. Similarly toNLRP3 inflammasome activation, apoptosis of virus-in-
fected cells was abrogated in the presence of cathepsin inhibitors [25].
We have also characterized the phosphoproteome of IAV infected
human MDMs using phosphopeptide enrichment with IMAC
(immobilized metal ion affinity chromatography) combined with LC-
MS/MS analysis [31]. We identified N4000 nonredundant phosphosites
and the phosphorylation status ofmore than one thousandmacrophage
proteins was changed upon IAV infection. Bioinformatics analysis of the
phosphoproteome data indicated that the phosphorylation of proteins
involved in the ubiquitin/proteasome pathway and antiviral responses
were regulated during IAV infection. Similarly, proteins involved in
small GTPase-, mitogen-activated protein kinase-, and cyclin-depen-
dent kinase (CDK) -signaling were regulated by phosphorylation upon
IAV infection. In particular, IAV infection had a major influence on the
phosphorylation profiles of a large number of CDK substrates. Function-
al studies with CDK inhibitors prevented IAV replication both in vitro
and in vivo [31]. Therefore targeting these kinases with small-molecule
inhibitors could be a novel way to treat severe IAV infections. The data
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replication can be new targets of antiviral drugs. In addition to analyzing
phosphorylation changes in host proteins, also the phosphorylation of
influenza virus proteins has been analyzed with proteomics. Hutchin-
son et al. utilized LC-MS/MS to map the phosphoproteomes of different
IAV strains and one influenza B strain [32]. They identified 36 novel
phosphorylation sites in influenza proteins. The study showed a key
role for phosphorylation in the IAV life cycle. Very recently, also the
phosphoproteome of Herpes Simplex Virus-1 (HSV-1) was mapped
[33]. Kulej et al. identified 67 viral proteins and quantified 571 phos-
phorylation events (465 with high confidence site localization) on
viral proteins. Together these studies showed that phosphorylation
events are abundant on viral proteins, and suggests that inhibition of
viral protein phosphorylation could be a novel antiviral strategy.
2.4. MS-based proteomics to characterize HIV-1 infection in human
macrophages
Several studies have utilizedMDMs as cell models to study the inter-
play betweenmacrophages andHIV-1. Kraft-Terry and co-workers used
pulsed stable isotope labeling of amino acids in cell culture (pSILAC) to
study alterations in protein synthesis in MDMs following HIV-1 infec-
tion [34]. Expression of proteins related to antigen presentation and in-
terferon-induced antiviral response were substantially up-regulated in
HIV-1-infected MDMs. In contrast, proteins involved in metabolic and
DNA packaging activities were down-regulated in macrophages infect-
ed with HIV-1. This study highlights a range of anti-retroviral mecha-
nisms that develop in macrophages to prevent spread of HIV-1.
Haverland et al. utilized SWATH-MS to study protein expression in un-
infected and HIV-1-infected MDMs [35]. They identified and quantified
3608 proteins of which 420 were differentially expressed upon HIV-1
infection. Bioinformatics analyses showed that especially the expression
of transcription regulator proteins was regulated by infection. In addi-
tion, dysregulation of RNA processing was seen. Both aforementioned
studies indicate that although macrophages can mount substantial
anti-retroviral response, HIV-1 can regulate the expression of host pro-
teins that promote virus survival [34–35].
Barrero et al. utilized SILAC to study the effect of HIV-1 protein Vpr
on macrophage protein expression [36]. They used monocytic U937
cells which were differentiated into macrophages and these cells were
transduced with adenovirus harboring the Vpr gene. Forced expression
of Vpr altered the expression of 136 proteins and the data showed al-
tered expression of many proteins related to cell metabolism. The au-
thors conclude that HIV-1 hijacks macrophages via Vpr to express
proteins that facilitate viral replication as well as long-term survival of
macrophages [36].
2.5. Proteomics to study macrophage response to porcine virus infection
Quantitative proteomics has been used to study changes in protein
expression levels in pulmonary alveolarmacrophages (PAMs) following
porcine reproductive and respiratory syndrome virus (PRRSV) and por-
cine circovirus type 2 (PCV2) infection using both 2-DE and MS-based
proteomics [37–40].
Ding et al. used used 2-DEwith silver-staining to characterize PRRSV
infection 24 hpi [37] and Zhou et al. used DIGE to compare macrophage
response to highly pathogenic PRRSV strain and attenuated strain at 48
hpi [38]. Ding et al. identified 29 proteins to be regulated upon infection.
These were related to morphogenesis, protein synthesis, metabolism,
stress response, the ubiquitin–proteasome pathway and signal trans-
duction [37]. Zhou et al. found that 153proteins had significant different
expression upon expression in DIGE analysis, and were able to identify
24 proteins from the gel. The virulent strain showed upregulated ex-
pression of pyruvate kinase M2, heat shock protein beta-1, and protea-
some subunit alpha type 6 suggesting that these proteins are involved in
the pathogenic mechanisms of PRRSV [38].PRRSV and PCV2 infection in macrophages have also been studied
utilizing iTRAQ-labeling and LC-MS/MS analysis of total cellular lysates
[39,40]. Both these kinetic studies identified N800 proteins and showed
altered expression of approximately 150 proteins upon infection. These
studies showed that in response to PRRSV and PCV2 infection differen-
tially expressed proteins are related to biological processes including
virus binding, cell structure, signal transduction, and cell adhesion [39,
40].
In addition, label-free quantitative phosphoproteomic analysis has
been used to analyze protein phosphorylation changes in PAMs follow-
ing PRRSV infection [41]. PRRSV infection of PAMs altered the phos-
phorylation status of over 240 proteins. Interaction analysis of the
data revealed that proteins that were regulated by phosphorylation fol-
lowing PRRSV infection are involved in cellular assembly and organiza-
tion, protein synthesis, molecular transport, and signal transduction.
Pathway analysis in turn suggested that inflammatory cytokine produc-
tion following PRRSV infection is likely due to the activation ofmitogen-
activated protein kinases and NF-κB signal pathway [41].3. Global protein secretion studies of virally infected macrophages
Protein secretion throughmultiple pathways is an important part of
immune responses. Immune cells secrete for example small soluble pro-
teins, cytokines and chemokines that are needed for proper coordina-
tion of host cell response to different pathogens. However, recent
system-level characterizations using proteomics methods have shown
that immune cells activate a much more global protein secretion than
just secretion of cytokines and chemokines [42,43]. We have extensive-
ly studied global protein secretion from human macrophages upon dif-
ferent activation stimuli using various proteomics workflows including
2-DE, GeLC-MS/MS, and iTRAQ [25,30,44–50]. From the technical point
of view it is important in these analyses to use serum-free growthmedia
and test the cell culture conditions for optimal cell viability. This is crit-
ical for obtaining good quality proteome data with minimal or no con-
tamination from serum proteins and to avoid identifying proteins
leaking from dying cells. We used iTRAQ to characterize macrophage
secretome upon IAV and herpes simplex virus 1 (HSV-1) infection [25,
44]. HSV-1 is a common pathogen infecting the majority of people
worldwide at some stage in their lives. It is an icosahedral, enveloped,
nuclear-replicating, double-stranded DNA virus. Our studies revealed
massive release of danger signal proteins and identified secreted host
factors that have a role in antiviral defense in response to IAV and
HSV-1 infection in MDMs. In addition, these studies also revealed that
many interferon-inducible proteins are secreted in response to viral in-
fection [25,44]. The results suggest that interferon-inducible proteins
have important extracellular antiviral functions.
In addition to viral infection, we have characterized macrophage
secretome upon stimulation upon ATP, monosodium urate (MSU), β-
glucans and intracellular lipopolysaccaharide (LPS) stimulation [45–
48,50]. Extracellular ATP and MSU are endogenous danger signals
known to activate inflammatory responses. β-glucans are themain con-
stituents of fungal cell walls and LPS is themajor cell wall component of
Gram-negative bacteria. Interestingly, bioinformatic characterization of
all the proteins identified from macrophage secretomes upon different
stimuli revealed that most of the proteins do not have the signal se-
quence required for classical ER/Golgi-mediated secretion [25,44,45,
47,50]. Proteins that do not carry an N-terminal signal peptide are re-
leased unconventionally. They are packed into various types of mem-
brane-enclosed structures, collectively called “extracellular vesicles”
(EVs). Exosomes are small, 30–150 nmmembrane vesicles secreted by
most cell types in vitro. ExoCarta is a database providing the contents
that have been identified in exosomes in multiple organisms [51].
Most of the proteins identified from macrophage secretomes were
found in ExoCarta. These proteomics studies indicate that vesicle-medi-
ated protein secretion is the key secretory pathway activated in
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ger signals.
Also protein secretion upon HIV infection has been studied using
proteomics. Already ten years ago Ciborowski et al. published
secretome analysis of HIV-1-infected human MDMs using SDS-PAGE
and MS [52]. Differentially secreted proteins included enzymes, cyto-
skeletal, redox, and immunoregulatory proteins. The key findings of
this study were validated by Western blot analysis. Secretome analysis
has been performed in macrophages cultured from peripheral blood
mononuclear cells isolated from women having HIV-1 associated with
neurocognitive disorders [53]. This study identified possible biomarkers
for HIV-1 associated with neurocognitive disorders. In addition, AP-MS
has been used to generate an interactomemap of host cathepsin B –pro-
tein fromuninfected andHIV-1-infectedMDMcell culture supernatants
[54]. The novel data presented in the study indicate that cathepsin B and
its' interacting proteins secreted by HIV-1-infected macrophages con-
tribute to neuronal apoptosis.
EVs are important for intercellular communication. Most attention
so far has focused on tumor-derived EVs. However, there is increasing
evidence that EVs from both non-immune and immune cells have im-
portant roles in immune regulation. When released from stimulated
cells, they have been shown to modulate the immune response. To
gain detailed information on EV-mediated protein secretion events trig-
gered by IAV infection we analyzed the proteome changes in EVs re-
leased from macrophages upon IAV infection using GeLC-MS/MS [49].
Proteins secreted in response to IAV infection included many proteins
involved in translation, such as components of spliceosome machinery
and the ribosome. The data also shows that EVs derived from IAV-infect-
edmacrophages contain antiviral cytokines, fatty acid-binding proteins,
copper metabolism Murr-1 domain proteins, and autophagy-related
proteins. These results suggest EV-mediated protein secretion has an
important role inmacrophages antiviral response. In addition to viral in-
fections, we have seen that EV-mediated protein secretion is activated
also in response to bacterial and fungal infections [46,50].
Kadiu et al. characterized the proteomes of EVs, including exosomes
and microvesicles, that were immunoaffinity purified form uninfected
and HIV-infected MDMs [55]. They observed mature HIV-1 by electron
microscopy in exosomes, and exosomes contained 7–17% viral proteins
compared to total protein content. The results of this study suggest an
essential role for exosomes as facilitators of HIV-1 infection. In general,
HIV-1 infection is modulated by exosomes in manyways and exosomes
are targeted by HIV-1-derived factors [56].
Viruses use virions to spread between hosts, and virions often con-
tain many host proteins that are required for viral transmission. Hutch-
inson and co-workers utilized ultracentrifugation through a sucrose
gradient and MS to gain detailed quantitative information about the
protein composition of virions formed by different influenza viruses
[57]. This study showed that conserved virion architecture is main-
tained across different combinations of virus and host. They also dem-
onstrate that virions have many host proteins that are found in
exosomes. The data suggests a new concept for virus spread: IAVs utilize
vesicles in their exit from infected cells [57]. Linde and co-workers have
utilized iTRAQ to studywhich host proteins are incorporated into HIV-1
virions in CD4-positive T cells and in MDMs [58]. Many of these host
proteins have been shown to be relevant to the HIV lifecycle and there-
fore may be novel targets for anti-retroviral therapy.
4. Concluding remarks
The term ‘proteome’ was introduced a little over twenty years ago
and the possibilities proteomics could offer for biomedical research
and drug discovery were realized very soon after that [59–61]. Howev-
er, this first ‘proteomics hype’ encountered serious difficulties with pro-
teomics methods being not sensitive and robust enough for routine
analysis. After intensive period of development for MS-instruments,
data analysis tools, and sample preparation methods proteomics hasreached the levelwhere it is possible to identify, quantify and character-
ize thousands of proteins from limited amount of cellular samples in
one experiment. An elegant demonstration of this is a very recent
paper by Rieckmann et al. [43] where the authors describe a social net-
work architecture of human immune cells using quantitative proteo-
mics. They characterized 28 human primary hematopoietic cell
populations that were sorted by flow cytometry using single-run MS-
analysis approach. This resulted in the identification of approx. 7500
proteins per measurement [43].
Newdevelopments in proteomics also constantly provide novel pos-
sibilities for advanced proteome analysis. An example of an emerging
proteomics techniquewhich is likely to findwide-spreaduse in virology
and immunology in general is single-cell proteomics usingmass cytom-
etry. It combines the cellular analysis principles of traditional fluores-
cence-based flow cytometry with the selectivity and quantitative
power of inductively coupled plasma-mass spectrometry. With mass
cytometry it is possible to multiplex up to 40 independent measure-
ments and gain comprehensive understanding of cell phenotypes, sig-
naling pathways and function on a single cell level [62,63].
Proteomics has already significantly contributed to our understand-
ing of macrophage response to viral infection, and identified several
hundreds of host proteins regulated by different viruses. Most of these
studies have been focusing on analyzing changes in protein expression
levels upon infection. To get more complete view on host response to
viral infection, future studies should also focus on analyzing how viral
infection regulates host proteins' post-translational modifications
(PTMs) on a global scale. There are already some phosphoproteome
studies on macrophage response to viral infection [31,41] but no other
PTMs have been studied on a global scale. An especially interesting
PTM in this respect is ubiquitination which is known to be have cross-
talk between protein phosphorylation in innate immunity [64,65]. Sev-
eral studies have shown that protein secretion is an important part of
macrophages response to viral infection [25,44,49]. Here, future studies
are needed to elucidate the role of unconventional protein secretion in
antiviral response. For this, the proteome composition of EVs secreted
upon viral infection need to be first characterized, and also the possible
PTMs in EV proteins. In addition, we and others have shown that EV-
mediated protein secretion is induced following NLRP3 inflammasome
activation [45,46,48,66]. In future studies proteomics techniques could
be exploited to define the intracellular signaling pathways that are es-
sential for the activation EV-mediated protein secretion induced by
virus-activated NLRP3 inflammasome.
In summary proteomics offers unique opportunities for in-depth
elucidation of host response to viral infection and host-virus interac-
tions, and themethods have reached the statewhere proteomics should
be routinely applied to virology research. However, this is still not the
case for most laboratories focusing their research in virology. To have
true integration of proteomics into virology more education is needed
for biomedical students and researchers so that they would understand
how proteomics could contribute to their research. Also multidisciplin-
ary research having seamless collaboration between virology, proteo-
mics and bioinformatics researchers is needed to fully utilize the
possibilities proteomics can offer for fundamental new discoveries in
virology.
Transparency document
The Transparency document associated with this article can be
found, in online version.References
[1] H. Koppensteiner, R. Brack-Werner, M. Schindler, Macrophages and their relevance
in human immunodeficiency virus type I infection, Retrovirology 9 (2012) 82.
[2] X.J. Meng, Emerging and re-emerging swine viruses, Transbound. Emerg. Dis. 59
(Suppl. 1) (2012) 85–102.
106 T.A. Nyman, S. Matikainen / Journal of Proteomics 180 (2018) 99–107[3] M.P. Weekes, P. Tomasec, E.L. Huttlin, C.A. Fielding, D. Nusinow, R.J. Stanton, E.C.
Wang, R. Aicheler, I. Murrell, G.W. Wilkinson, P.J. Lehner, S.P. Gygi, Quantitative
temporal viromics: an approach to investigate host-pathogen interaction, Cell 157
(2014) 1460–1472.
[4] X. Luo, K.A. Carlson, V. Wojna, R. Mayo, T.M. Biskup, J. Stoner, J. Anderson, H.E.
Gendelman, L.M. Meléndez, Macrophage proteomic fingerprinting predicts HIV-1-
associated cognitive impairment, Neurology 60 (2003) 1931–1937.
[5] K.A. Carlson, P. Ciborowski, C.N. Schellpeper, T.M. Biskup, R.F. Shen, X. Luo, C.J.
Destache, et al., Proteomic fingerprinting of HIV-1-infected human monocyte-de-
rived macrophages: a preliminary report, J. Neuroimmunol. 147 (2004) 35–42.
[6] V. Wojna, K.A. Carlson, X. Luo, R. Mayo, L.M. Meléndez, E. Kraiselburd, H.E.
Gendelman, Proteomic fingerprinting of human immunodeficiency virus type 1-as-
sociated dementia from patient monocyte-derived macrophages: a case study, J.
Neuro-Oncol. 10 (Suppl. 1) (2004) 74–81.
[7] I. Kadiu, M. Ricardo-Dukelow, P. Ciborowski, H.E. Gendelman, Cytoskeletal protein
transformation in HIV-1-infected macrophage giant cells, J. Immunol. 178 (2007)
6404–6415.
[8] C. Luciano-Montalvo, P. Ciborowski, F. Duan, H.E. Gendelman, L.M. Melendez, Prote-
omic analyses associate cystatin B with restricted HIV-1 replication in placental
macrophages, Placenta 29 (2008) 1016–1023.
[9] K. Garcia, V. Garcia, J. Perez Laspiur, F. Duan, L.M. Melendez, Characterization of the
placental macrophage secretome: implications for antiviral activity, Placenta 30
(2009) 149–155.
[10] D.M. Toro-Nieves, Y. Rodriguez, M. Plaud, P. Ciborowski, F. Duan, J. Perez Laspiur, V.
Wojna, et al., Proteomic analyses of monocyte-derived macrophages infected with
human immunodeficiency virus type 1 primary isolates from Hispanic women
with and without cognitive impairment, J. Neuro-Oncol. 15 (2009) 36–50.
[11] M.R. Donnelly, P. Ciborowski, Proteomics, biomarkers, and HIV-1: a current perspec-
tive, Proteomics Clin. Appl. 10 (2016) 110–125.
[12] K.K. Lum, I.M. Cristea, Proteomic approaches to uncovering virus-host protein inter-
actions during the progression of viral infection, Expert Rev. Proteomics 13 (2016)
325–340.
[13] N.S. Heaton, N. Moshkina, R. Fenouil, T.J. Gardner, S. Aguirre, P.S. Shah, N. Zhao, L.
Manganaro, J.F. Hultquist, J. Noel, D. Sachs, J. Hamilton, P.E. Leon, A. Chawdury, S.
Tripathi, C. Melegari, L. Campisi, R. Hai, G. Metreveli, A.V. Gamarnik, A. García-
Sastre, B. Greenbaum, V. Simon, A. Fernandez-Sesma, N.J. Krogan, L.C. Mulder,
H. van Bakel, D. Tortorella, J. Taunton, P. Palese, I. Marazzi, Targeting viral
Proteostasis limits influenza virus, HIV, and dengue virus infection, Immunity
44 (2016) 46–58.
[14] M.H. Sieweke, J.E. Allen, Beyond stem cells: self-renewal of differentiated macro-
phages, Science 342 (2013) 1242974, http://dx.doi.org/10.1126/science.1242974.
[15] K.S. Akagawa, I. Komuro, H. Kanazawa, T. Yamazaki, K. Mochida, F. Kishi, Functional
heterogeneity of colony-stimulating factor-induced human monocyte-derived mac-
rophages, Respirology 11 (Jan 2006) (Suppl:S32-6).
[16] L. Liu, J. Zhou, Y. Wang, R.J. Mason, C.J. Funk, Y. Du, Proteome alterations in primary
human alveolar macrophages in response to influenza a virus infection, J. Proteome
Res. 11 (2012) 4091–4101.
[17] Z. Qin, The use of THP-1 cells as a model for mimicking the function and regulation
of monocytes and macrophages in the vasculature, Atherosclerosis 221 (2012)
2–11.
[18] R. Ganji, S. Dhali, A. Rizvi, S. Rapole, S. Banerjee, Understanding HIV-mycobacteria
synergism through comparative proteomics of intra-phagosomal mycobacteria dur-
ing mono- and HIV co-infection, Sci Rep 6 (2016) 22060, http://dx.doi.org/10.1038/
srep22060.
[19] T. Ohman, J. Rintahaka, N. Kalkkinen, S. Matikainen, T.A. Nyman, Actin and RIG-I/
MAVS signaling components translocate to mitochondria upon influenza a virus in-
fection of human primary macrophages, J. Immunol. 182 (2009) 5682–5692.
[20] J. Zhu,W. Zou, G. Jia, H. Zhou, Y. Hu, M. Peng, H. Chen, M. Jin, Analysis of cellular pro-
teome alterations in porcine alveolar macrophages infected with 2009 (H1N1) and
classical swine H1N1 influenza viruses, J. Proteome 75 (2012) 1732–1741.
[21] T. Ohman, N. Lietzen, E. Valimaki, J. Melchjorsen, S. Matikainen, T.A. Nyman, Cytosol-
ic RNA recognition pathway activates 14-3-3 protein mediated signaling and cas-
pase-dependent disruption of cytokeratin network in human keratinocytes, J.
Proteome Res. 9 (2010) 1549–1564.
[22] T. Wang, N. Gong, J. Liu, I. Kadiu, S.D. Kraft-Terry, R.L. Mosley, D.J. Volsky, P.
Ciborowski, H.E. Gendelman, Proteomic modeling for HIV-1 infected microglia-as-
trocyte crosstalk, PLoS One 3 (2008), e2507.
[23] T. Wang, N. Gong, J. Liu, I. Kadiu, S.D. Kraft-Terry, J.D. Schlautman, P. Ciborowski,
et al., HIV-1-infected astrocytes and the microglial proteome, J. NeuroImmune
Pharmacol. 3 (2008) 173–186.
[24] C.Y. Cheung, E.Y. Chan, A. Krasnoselsky, D. Purdy, A.T. Navare, J.T. Bryan, C.K. Leung,
et al., H5N1 virus causes significant perturbations in host proteome very early in in-
fluenza virus-infected primary human monocyte-derived macrophages, J Infect Dis
206 (2012) 640–645.
[25] N. Lietzen, T. Ohman, J. Rintahaka, I. Julkunen, T. Aittokallio, S. Matikainen, T.A.
Nyman, Quantitative subcellular proteome and secretome profiling of influenza
a virus-infected human primary macrophages, PLoS Pathog. 7 (2011),
e1001340.
[26] J. Pirhonen, T. Sareneva, M. Kurimoto, I. Julkunen, S. Matikainen, Virus infection ac-
tivates IL-1 beta and IL-18 production in human macrophages by a caspase-1-de-
pendent pathway, J. Immunol. 162 (1999) 7322–7329.
[27] T. Ichinohe, H.K. Lee, Y. Ogura, R. Flavell, A. Iwasaki, Inflammasome recognition of in-
fluenza virus is essential for adaptive immune responses, J. Exp. Med. 206 (2009)
79–87.
[28] I.C. Allen, M.A. Scull, C.B. Moore, E.K. Holl, E. McElvania-TeKippe, D.J. Taxman, E.H.
Guthrie, R.J. Pickles, J.P. Ting, The NLRP3 inflammasome mediates in vivo innateimmunity to influenza a virus through recognition of viral RNA, Immunity 30
(2009) 556–565.
[29] P.G. Thomas, P. Dash, J.R. Aldridge Jr., A.H. Ellebedy, C. Reynolds, A.J. Funk, W.J.
Martin, M. Lamkanfi, R.J. Webby, K.L. Boyd, P.C. Doherty, T.D. Kanneganti, The intra-
cellular sensor NLRP3 mediates key innate and healing responses to influenza a
virus via the regulation of caspase-1, Immunity 30 (2009) 566–575.
[30] J. Rintahaka, N. Lietzen, T. Ohman, T.A. Nyman, S. Matikainen, Recognition of cyto-
plasmic RNA results in cathepsin-dependent inflammasome activation and apopto-
sis in human macrophages, J. Immunol. 186 (2011) 3085–3092.
[31] S. Soderholm, D.E. Kainov, T. Ohman, O.V. Denisova, B. Schepens, E. Kulesskiy, S.Y.
Imanishi, et al., Phosphoproteomics to characterize host response during influenza
a virus infection of human macrophages, Mol. Cell. Proteomics 15 (2016)
3203–3219.
[32] E.C. Hutchinson, E.M. Denham, B. Thomas, D.C. Trudgian, S.S. Hester, G. Ridlova, A.
York, L. Turrell, E. Fodor,Mapping the phosphoproteome of influenza a and B viruses
by mass spectrometry, PLoS Pathog. 8 (11) (2012), e1002993. .
[33] K. Kulej, D.C. Avgousti, S. Sidoli, C. Herrmann, A.N. Della Fera, E.T. Kim, B.A. Garcia,
M.D. Weitzman, Time-resolved global and chromatin proteomics during herpes
simplex virus type 1 (HSV-1) infection, Mol. Cell. Proteomics 16 (2017) S92–S107
(4 suppl 1).
[34] S.D. Kraft-Terry, I.L. Engebretsen, D.K. Bastola, H.S. Fox, P. Ciborowski, H.E.
Gendelman, Pulsed stable isotope labeling of amino acids in cell culture uncovers
the dynamic interactions between HIV-1 and the monocyte-derived macrophage,
J. Proteome Res. 10 (2011) 2852–2862.
[35] N.A. Haverland, H.S. Fox, P. Ciborowski, Quantitative proteomics by SWATH-MS re-
veals altered expression of nucleic acid binding and regulatory proteins in HIV-1-in-
fected macrophages, J. Proteome Res. 13 (2014) 2109–2119.
[36] C.A. Barrero, P.K. Datta, S. Sen, S. Deshmane, S. Amini, K. Khalili, S. Merali, HIV-1 Vpr
modulates macrophage metabolic pathways: a SILAC-based quantitative analysis,
PLoS One 8 (2013), e68376. .
[37] Z. Ding, Z.J. Li, X.D. Zhang, Y.G. Li, C.J. Liu, Y.P. Zhang, Y. Li, Proteomic alteration of
Marc-145 cells and PAMs after infection by porcine reproductive and respiratory
syndrome virus, Vet. Immunol. Immunopathol. 145 (2012) 206–213.
[38] Y.J. Zhou, J.P. Zhu, T. Zhou, Q. Cheng, L.X. Yu, Y.X. Wang, S. Yang, et al., Identification
of differentially expressed proteins in porcine alveolar macrophages infected with
virulent/attenuated strains of porcine reproductive and respiratory syndrome
virus, PLoS One 9 (2014), e85767.
[39] Q. Lu, J. Bai, L. Zhang, J. Liu, Z. Jiang, J.J. Michal, Q. He, et al., Two-dimensional liquid
chromatography-tandem mass spectrometry coupled with isobaric tags for relative
and absolute quantification (iTRAQ) labeling approach revealed first proteome pro-
files of pulmonary alveolar macrophages infected with porcine reproductive and re-
spiratory syndrome virus, J. Proteome Res. 11 (2012) 2890–2903.
[40] J. Liu, J. Bai, Q. Lu, L. Zhang, Z. Jiang, J.J. Michal, Q. He, et al., Two-dimensional liquid
chromatography-tandem mass spectrometry coupled with isobaric tags for relative
and absolute quantification (iTRAQ) labeling approach revealed first proteome pro-
files of pulmonary alveolar macrophages infected with porcine circovirus type 2, J.
Proteome 79 (2013) 72–86.
[41] R. Luo, L. Fang, H. Jin, D. Wang, K. An, N. Xu, H. Chen, et al., Label-free quantitative
phosphoproteomic analysis reveals differentially regulated proteins and pathway
in PRRSV-infected pulmonary alveolar macrophages, J. Proteome Res. 13 (2014)
1270–1280.
[42] F. Meissner, R.A. Scheltema, H.J. Mollenkopf, M. Mann, Direct proteomic quantifica-
tion of the secretome of activated immune cells, Science 340 (2013) 475–478.
[43] J.C. Rieckmann, R. Geiger, D. Hornburg, T. Wolf, K. Kveler, D. Jarrossay, F. Sallusto, S.S.
Shen-Orr, A. Lanzavecchia, M. Mann, F. Meissner, Social network architecture of
human immune cells unveiled by quantitative proteomics, Nat. Immunol. (Mar 6
2017) (Epub ahead of print).
[44] J.J. Miettinen, S. Matikainen, T.A. Nyman, Global secretome characterization of her-
pes simplex virus 1-infected human primary macrophages, J. Virol. 86 (2012)
12770–12778.
[45] E. Valimaki, J.J. Miettinen, N. Lietzen, S. Matikainen, T.A. Nyman, Monosodium urate
activates Src/Pyk2/PI3 kinase and cathepsin dependent unconventional protein se-
cretion from human primary macrophages, Mol. Cell. Proteomics 12 (2013)
749–763.
[46] W. Cypryk, T. Ohman, E.L. Eskelinen, S. Matikainen, T.A. Nyman, Quantitative prote-
omics of extracellular vesicles released from human monocyte-derived macro-
phages upon beta-glucan stimulation, J. Proteome Res. 13 (2014) 2468–2477.
[47] T. Ohman, L. Teirila, A.M. Lahesmaa-Korpinen, W. Cypryk, V. Veckman, S. Saijo, H.
Wolff, et al., Dectin-1 pathway activates robust autophagy-dependent unconven-
tional protein secretion in human macrophages, J. Immunol. 192 (2014)
5952–5962.
[48] E. Valimaki, W. Cypryk, J. Virkanen, K. Nurmi, P.M. Turunen, K.K. Eklund, K.E.
Akerman, et al., Calpain activity is essential for ATP-driven unconventional vesi-
cle-mediated protein secretion and inflammasome activation in human macro-
phages, J. Immunol. 197 (2016) 3315–3325.
[49] W. Cypryk, M. Lorey, A. Puustinen, T.A. Nyman, S. Matikainen, Proteomic and Bioin-
formatic characterization of extracellular vesicles released from human macro-
phages upon influenza a virus infection, J. Proteome Res. 16 (2017) 217–227.
[50] M.B. Lorey, K. Rossi, K.K. Eklund, T.A. Nyman, S. Matikainen, Global characterization
of protein secretion from humanmacrophages following non-canonical caspase-4/5
inflammasome activation, Mol. Cell. Proteomics (2017).
[51] S. Keerthikumar, D. Chisanga, D. Ariyaratne, H. Al Saffar, S. Anand, K. Zhao, M.
Samuel, M. Pathan, M. Jois, N. Chilamkurti, L. Gangoda, S. Mathivanan, ExoCarta: a
web-based compendium of exosomal cargo, J. Mol. Biol. 428 (2016) 688–692.
[52] P. Ciborowski, I. Kadiu, W. Rozek, L. Smith, K. Bernhardt, M. Fladseth, M. Ricardo-
Dukelow, H.E. Gendelman, Investigating the human immunodeficiency virus type
107T.A. Nyman, S. Matikainen / Journal of Proteomics 180 (2018) 99–1071-infected monocyte-derived macrophage secretome, Virology 363 (2007)
198–209.
[53] K. Colon, J. Perez-Laspiur, R. Quiles, Y. Rodriguez, V.Wojna, S.A. Shaffer, J. Leszyk, R.L.
Skolasky Jr., L.M. Melendez, Macrophage secretome fromwomenwith HIV-associat-
ed neurocognitive disorders, Proteomics Clin. Appl. 10 (2016) 136–143.
[54] Y.M. Cantres-Rosario, N. Hernandez, K. Negron, J. Perez-Laspiur, J. Leszyk, S.A.
Shaffer, L.M. Melendez, Interacting partners of macrophage-secreted cathepsin B
contribute to HIV-induced neuronal apoptosis, AIDS 29 (2015) 2081–2092.
[55] I. Kadiu, P. Narayanasamy, P.K. Dash,W. Zhang, H.E. Gendelman, Biochemical and bi-
ologic characterization of exosomes and microvesicles as facilitators of HIV-1 infec-
tion in macrophages, J. Immunol. 189 (2012) 744–754.
[56] M.N. Madison, C.M. Okeoma, Exosomes: implications in HIV-1 pathogenesis, Viruses
7 (2015) 4093–4118.
[57] E.C. Hutchinson, P.D. Charles, S.S. Hester, B. Thomas, D. Trudgian, M. Martínez-
Alonso, E. Fodor, Conserved and host-specific features of influenza virion architec-
ture, Nat. Commun. 5 (2014) 4816.
[58] M.E. Linde, D.R. Colquhoun, C. Ubaida Mohien, T. Kole, V. Aquino, R. Cotter, N.
Edwards, J.E. Hildreth, D.R. Graham, The conserved set of host proteins incorporated
into HIV-1 virions suggests a common egress pathway in multiple cell types, J. Pro-
teome Res. 12 (2013) 2045–2054.
[59] P. Kahn, From genome to proteome: looking at a cell's proteins, Science (1995)
270.369–270.370.
[60] M.R. Wilkins, J.C. Sanchez, A.A. Gooley, R.D. Appel, I. Humphery-Smith, D.F.
Hochstrasser, K.L. Williams, Progress with proteome projects: why all proteins
expressed by a genome should be identified and how to do it, Biotechnol. Genet.
Eng. Rev. 13 (1996) 19–50.
[61] C. O'Brien, Protein fingerprints, proteome projects and implications for drug discov-
ery, Mol. Med. Today 2 (1996) 316.
[62] K.R. Atkuri, J.C. Stevens, H. Neubert, Mass cytometry: a highly multiplexed single-
cell technology for advancing drug development, Drug Metab. Dispos. 43 (2015)
227–233.
[63] C. Giesen, H.A.Wang, D. Schapiro, N. Zivanovic, A. Jacobs, B. Hattendorf, P.J. Schüffler,
D. Grolimund, J.M. Buhmann, S. Brandt, Z. Varga, P.J. Wild, D. Günther, B.
Bodenmiller, Highly multiplexed imaging of tumor tissues with subcellular resolu-
tion by mass cytometry, Nat. Methods 11 (2014) 417–422.
[64] S.M. Heaton, N.A. Borg, V.M. Dixit, Ubiquitin in the activation and attenuation of in-
nate antiviral immunity, J. Exp. Med. 213 (2016) 1–13.
[65] C. Chiang, M.U. Gack, Post-translational control of intracellular pathogen sensing
pathways, Trends Immunol. 38 (2017) 39–52.
[66] Y. Zhang, F. Liu, Y. Yuan, C. Jin, C. Chang, Y. Zhu, X. Zhang, C. Tian, F. He, J. Wang,
Inflammasome-derived exosomes activate NF-κB signaling inmacrophages, J. Prote-
ome Res. 16 (2017) 170–178.
[67] M. Larance, A.I. Lamond, Multidimensional proteomics for cell biology, Nat. Rev. Mol.
Cell Biol. 16 (2015) 269–280.[68] R. Aebersold, M. Mann, Mass-spectrometric exploration of proteome structure and
function, Nature 537 (2016) 347–355.
[69] L. von Stechow, C. Francavilla, J.V. Olsen, Recent findings and technological advances
in phosphoproteomics for cells and tissues, Expert Rev. Proteomics 12 (2015)
469–487.
[70] M. Ricardo-Dukelow, I. Kadiu, W. Rozek, J. Schlautman, Y. Persidsky, P. Ciborowski,
G.D. Kanmogne, et al., HIV-1 infected monocyte-derived macrophages affect the
human brain microvascular endothelial cell proteome: new insights into blood-
brain barrier dysfunction for HIV-1-associated dementia, J. Neuroimmunol. 185
(2007) 37–46.
[71] I. Kadiu, H.E. Gendelman, Macrophage bridging conduit trafficking of HIV-1 through
the endoplasmic reticulum and Golgi network, J. Proteome Res. 10 (2011)
3225–3238.
[72] P. Ciborowski, Y. Enose, A. Mack, M. Fladseth, H.E. Gendelman, Diminished matrix
metalloproteinase 9 secretion in human immunodeficiency virus-infectedmononu-
clear phagocytes: modulation of innate immunity and implications for neurological
disease, J. Neuroimmunol. 157 (2004) 11–16.
[73] J.N. Brown, J.J. Kohler, C.R. Coberley, J.W. Sleasman,M.M. Goodenow, HIV-1 activates
macrophages independent of toll-like receptors, PLoS One 3 (2008), e3664. .
[74] C. Luciano-Montalvo, L.M. Meléndez, Cystatin B associates with signal transducer
and activator of transcription 1 in monocyte-derived and placental macrophages,
Placenta 30 (2009) 464–467.
[75] S. Pathak, G.A. De Souza, T. Salte, H.G. Wiker, B. Asjo, HIV induces both a down-reg-
ulation of IRAK-4 that impairs TLR signalling and an up-regulation of the antibiotic
peptide dermcidin in monocytic cells, Scand. J. Immunol. 70 (2009) 264–276.
[76] X. Huang, D.K. Stone, F. Yu, Y. Zeng, H.E. Gendelman, Functional proteomic analysis
for regulatory T cell surveillance of the HIV-1-infectedmacrophage, J. Proteome Res.
9 (2010) 6759–6773.
[77] R.A. Raposo, B. Thomas, G. Ridlova,W. James, Proteomic-based identification of CD4-
interacting proteins in human primary macrophages, PLoS One 6 (2011), e18690. .
[78] M. Arainga, D. Guo, J. Wiederin, P. Ciborowski, J. McMillan, H.E. Gendelman, Oppos-
ing regulation of endolysosomal pathways by long-acting nanoformulated antire-
troviral therapy and HIV-1 in human macrophages, Retrovirology 12 (2015) 5.
[79] C. Du, H.F. Liu, Y.Z. Lin, X.F.Wang, J. Ma, Y.J. Li, X.Wang, et al., Proteomic alteration of
equine monocyte-derived macrophages infected with equine infectious anemia
virus, Proteomics 15 (2015) 1843–1858.
[80] E. Chertova, O. Chertov, L.V. Coren, J.D. Roser, C.M. Trubey, J.W. Bess Jr., R.C. Sowder
2nd, E. Barsov, B.L. Hood, R.J. Fisher, K. Nagashima, T.P. Conrads, T.D. Veenstra, J.D.
Lifson, D.E. Ott, Proteomic and biochemical analysis of purified human immunode-
ficiency virus type 1 produced from infected monocyte-derived macrophages, J.
Virol. 80 (2006) 9039–9052.
[81] S. Santos, Y. Obukhov, S. Nekhai, M. Bukrinsky, S. Iordanskiy, Virus-producing cells
determine the host protein profiles of HIV-1 virion cores, Retrovirology 9 (2012) 65.
